Related Experiment Videos

Bordetella pertussis surveillance in England and Wales: 1995-7

P G Van Buynder1, D Owen, J E Vurdien

  • 1Communicable Diseases Surveillance Centre, Colindale, UK.

Epidemiology and Infection
|February 29, 2000
PubMed

Insights

Pertussis (whooping cough) notifications are decreasing but cases are rising in young children and adolescents. Serotype 1,2 pertussis is increasing and causes more severe disease, highlighting the need for timely booster vaccinations.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Pertussis (whooping cough) surveillance data from England and Wales (1995-1997) were analyzed.
  • Trends in pertussis notifications, hospital admissions, and deaths were examined.
  • An enhanced laboratory-based surveillance system provided additional data.

Purpose of the Study:

  • To review available data sources on pertussis (whooping cough) for the period 1995-1997.
  • To identify trends in pertussis epidemiology, including age distribution and serotype prevalence.
  • To assess the impact of vaccination and potential interventions.

Main Methods:

  • Review of national surveillance data including notifications, hospital admissions, and deaths.
  • Analysis of trends in pertussis incidence and seasonality.
  • Examination of age-specific case proportions and serotype distribution.

Main Results:

  • Pertussis notifications exhibited a 3-year cycle but at reduced levels, with a slight seasonal peak.
  • An increasing proportion of cases occurred in younger, unvaccinated children, adolescents, and young adults.
  • Serotype 1,2 pertussis, associated with more severe disease, was increasing despite high vaccination rates.
  • Significant underreported mortality in infants was noted.
  • Preventative antibiotics reduced disease severity but were rarely used.

Conclusions:

  • Despite declining overall notifications, pertussis remains a significant threat, particularly to the very young.
  • Waning vaccine efficacy with age and the rise of serotype 1,2 necessitate improved vaccination strategies.
  • Timely booster vaccinations and early antibiotic treatment for contacts are crucial for reducing pertussis morbidity and mortality.

Related Concept Videos